Safety of garlic (allium sativum) and turmeric (curcuma domestica) extract in comparison with simvastatin on improving lipid profile in dyslipidemia patients

Journal of Medical Sciences (Faisalabad)

Volumn 13, Issue 1, 2013, Pages 10-18

  Sukandar, Elin Yulinah ^a   Sudjana, Primal ^b   Sigit, Joseph I ^a   Leliqia, Ni Putu E ^a   Lestari, Fetri ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^b Hasan Sadikin Hospital   (Indonesia)

Author keywords

Adverse events; Dyslipidemia; Garlic; Turmeric

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; CURCUMA LONGA EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GARLIC EXTRACT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; PARACETAMOL; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL; UREA; VASODILATOR AGENT; VITAMIN;

ABDOMINAL PAIN; ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; BLURRED VISION; BODY WEIGHT; BURNING SENSATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPNEA; ESOPHAGUS BURNING SENSATION; EVENING DOSAGE; FATIGUE; FEMALE; FLATULENCE; FLU LIKE SYNDROME; GARLIC BREATH; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HALITOSIS; HEART PALPITATION; HEMATOCRIT; HUMAN; HYPOGLYCEMIA; INCREASED APPETITE; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIPID ANALYSIS; LIVER FUNCTION TEST; MALE; MORNING DOSAGE; MUSCLE CRAMP; MUSCLE RIGIDITY; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PATIENT COMPLIANCE; POLYDIPSIA; POLYURIA; PROTHROMBIN TIME; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; THROMBOCYTE COUNT; UNSPECIFIED SIDE EFFECT; URINARY DYSFUNCTION; VOMITING;

EID: 84877277875     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2013.10.18     Document Type: Article

References (22)

1. Aronson, J.K., 2005. Meyler's Side Effects of Drugs. 15th Edn., Elsevier, UK.
2. Ashraf, R., K. Aamir, A.R. Shaikh and T. Ahmed, 2005. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J. Ayub. Med. Coll. Abbottabad, 17: 60-64.
3. Barnes, J., L.A. Anderson and J.D. Phillipson, 2007. Herbal Medicines. 3rd Edn., Pharmaceutical Press, London, ISBN: 9780853696230, Pages: 710.
4. Braun, L. and M. Cohen, 2007. Herbs and Natural Supplements-An Evidence-Based Guide. 2nd Edn., Elsevier, Australia.
5. Brunton, L.L., J.S. Lazo and K.L. Parker, 2006. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th Edn., Mc-Graw Hill's, New York.
6. Eidi, A., M. Eidi and E. Esmaeili, 2006. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine, 13: 624-629.
7. Hasimun, P., E.Y. Sukandar, I.K. Adnyana and D.H. Tjahjono, 2011. Synergistic effect of curcuminoid and S-methyl cysteine in regulation of cholesterol homeostasis. Int. J. Pharmacol., 7: 268-272.
8. Jang, E.M., M.S. Choi, U.J. Jung, M.J. Kim and H. J. Kimetah, 2008. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamster. Metabolism, 57: 1576-1583.
9. Kumar, A. and V. Singh, 2010. Atherogenic dyslipidemia and diabetes mellitus: What's new in the management area? Vase. Health Risk Manage., 6: 665-669.
10. Leon, A.S. and U.G. Bronas, 2009. Dyslipidemia and risk of coronary heart disease: Role of lifestyle approaches for its management. Am. J. Lifestyle Med., 3: 257-273.
11. Liu, L. and Y.Y. Yeh, 2002. S-alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes. J.Nutr., 132: 1129-1134.
12. Madkor, H.R., S.W. Mansour and G. Ramadan, 2011. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin-nicotinamide diabetic rats. Br. J. Nutr., 105: 1210-1217.
13. Moffatt, R. and B. Stamford, 2006. Lipid Metabolism and Health. Taylor and Francis Group, New York.
14. Pollex R.L., T.R. Joy and R.A. Hegele, 2008. Emerging antidyslipidemic drugs. Expert Opin. Emerg. Drugs, 13: 363-381.
15. Seo, K.I., M.S. Choi, U.J. Jung, H.J. Kim, J. Yeo, S.M. Jeon and M.K. Lee, 2008. Effect of curcumin supplementation on blood glucose, plasma insulin and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res., 52: 995-1004.
16. Stevinson, C., M.H. Pittler and E. Ernst, 2000. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann. Intern. Med., 19: 420-429.
17. Sukandar, E. Y., I. Fidrianny and A.N. Garmana, 2008. The influence of garlic bulbs and turmeric rhizomes extract on the fetus of Swiss webster mice. Maranatha Med. J., 8: 36-44.
18. Sukandar, E.Y., J.I. Sigit and R. Deviana, 2010a. Antihyperlipidemic and antidiabetic effect of combination of garlic and turmeric extract in rats. Indonesian J. Herbal Med., 1: 1-8.
19. Sukandar, E.Y., H. Permana, I.K. Adnyana, J.I. Sigit, R.A. Ilyas, P. Hasimun and D. Mardiyah, 2010b. Clinical study of turmeric (Curcuma longa L.) and garlic (Allium sativum L.) extracts as antihyperglycemic and antihyperlipidemic agent in type-2 diabetes-dyslipidemia patients. Int. J. Pharmacol., 6: 456-463.
20. Sukandar E.Y., Nurdewi and Elfahmi, 2012. Antihypercholesterolemic Effect of Combination of Guazuma ulmifolia lamk. leaves and Curcuma xanthorrhiza roxb. rhizomes extract in wistar rats. Int. J. Pharmacol., 8: 277-282.
21. Vinik, A.I., 2005. The metabolic basis of atherogenic dyslipidemia. Clin. Cornerstone, 7: 27-35.
22. WHO/LASO/IOTF., 2000. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Health Communications, Melbourne, Australia.